Welichem Successfully Completes Two Phase Ii Clinical Trials of Wbi-1001 Cream in Patients With Psoriasis and Atopic Dermatitis - Drugs.com MedNews
Links shared publicly online about this topic.
- 531total visits
Welichem Successfully Completes Two Phase Ii Clinical Trials of Wbi-1001 Cream in Patients With Psoriasis and Atopic Dermatitis - Drugs.com MedNews
VANCOUVER, Feb. 2 CNW - Welichem Biotech is pleased to announce the successful completion of two Phase II clinical trials with WBI-1001 on psoriasis and atopic
View full resource at drugs.com
Tags: Allergies, Eczema, Psoriasis, Dairy, Drug, Clinical Trial, Biotech
Most Recently Shared on February 4, 2011 at 2:09 pm By:
Welichem Successfully Completes Two Phase Ii Clinical Trials of Wbi-1001 Cream in Patients With Psoriasis ... http://bit.ly/gUcjOa #drug
Advertisement
